High-dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome.

María Paz Guerrero-Molina,Montserrat Morales-Conejo,Aitor Delmiro,María Morán,Cristina Domínguez-González,Elena Arranz-Canales,Ana Ramos-González,Joaquín Arenas,Miguel A Martín,Jesús González de la Aleja

European journal of neurology（2023）

引用 4|浏览8

暂无评分

摘要

ClinicalTrials.gov Identifier: NCT04948138. Initial release 24 June 2021, first patient enrolled 1 July 2021. https://clinicaltrials.gov/ct2/show/NCT04948138.

查看译文

关键词

MELAS syndrome,glutamate,glutamine supplementation,mitochondrial disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要